Skip to main content
Journal cover image

Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial.

Publication ,  Journal Article
Prasad, A; Stone, GW; Aymong, E; Zimetbaum, PJ; McLaughlin, M; Mehran, R; Garcia, E; Tcheng, JE; Cox, DA; Grines, CL; Gersh, BJ; CADILLAC trial,
Published in: Am Heart J
April 2004

BACKGROUND: Age is a strong independent predictor of outcomes after primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI). Whether lower rates of reperfusion success contribute to the poor prognosis in elderly patients is unknown. METHODS: A formal ST-segment analysis substudy was performed in 695 patients undergoing primary PCI for AMI in the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Reperfusion success (determined by the magnitude of ST-segment elevation resolution [STR] after PCI) was evaluated in 4 age groups: <50 years (n = 163), >or=50 to <60 years (n = 187), >or=60 to <70 years (n = 194), and >or=70 years (n = 151). RESULTS: There were no differences in the age groups for angiographic procedural success (>91% in all, P =.6), postprocedural Thrombolysis in Myocardial Infarction grade 3 flow (>94%, P =.8), and the proportions of patients with complete, partial, or absent STR (P >.8). However, rates of 30-day mortality (0.6%, 1.1%, 3.6%, 6.0%, respectively) and major adverse cardiac events (MACE; 2.5%, 4.8%, 6.2% 9.3%, respectively) increased with age. Rates of mortality and MACE were also inversely related to the magnitude of STR. Absent STR (hazard ratio, 3.00; 95% CI, 1.37-6.58; P =.006) and age (hazard ratio, 1.34; 95% CI, 1.01-1.77; P =.04) were independent predictors of 30-day MACE by using multivariable modeling. CONCLUSIONS: Lack of effective myocardial reperfusion is not a contributory mechanism responsible for the high morbidity and mortality rates observed in elderly patients. Nevertheless, advanced age and absent STR are both independent predictors of adverse outcomes after primary PCI, emphasizing the importance of successful reperfusion in the elderly population.

Duke Scholars

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

April 2004

Volume

147

Issue

4

Start / End Page

669 / 675

Location

United States

Related Subject Headings

  • Stents
  • Risk Factors
  • Proportional Hazards Models
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Platelet Aggregation Inhibitors
  • Myocardial Infarction
  • Multivariate Analysis
  • Middle Aged
  • Male
  • Immunoglobulin Fab Fragments
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Prasad, A., Stone, G. W., Aymong, E., Zimetbaum, P. J., McLaughlin, M., Mehran, R., … CADILLAC trial, . (2004). Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial. Am Heart J, 147(4), 669–675. https://doi.org/10.1016/j.ahj.2003.11.010
Prasad, Abhiram, Gregg W. Stone, Eve Aymong, Peter J. Zimetbaum, Michael McLaughlin, Roxana Mehran, Eulogio Garcia, et al. “Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial.Am Heart J 147, no. 4 (April 2004): 669–75. https://doi.org/10.1016/j.ahj.2003.11.010.
Prasad A, Stone GW, Aymong E, Zimetbaum PJ, McLaughlin M, Mehran R, et al. Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial. Am Heart J. 2004 Apr;147(4):669–75.
Prasad, Abhiram, et al. “Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial.Am Heart J, vol. 147, no. 4, Apr. 2004, pp. 669–75. Pubmed, doi:10.1016/j.ahj.2003.11.010.
Prasad A, Stone GW, Aymong E, Zimetbaum PJ, McLaughlin M, Mehran R, Garcia E, Tcheng JE, Cox DA, Grines CL, Gersh BJ, CADILLAC trial. Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial. Am Heart J. 2004 Apr;147(4):669–675.
Journal cover image

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

April 2004

Volume

147

Issue

4

Start / End Page

669 / 675

Location

United States

Related Subject Headings

  • Stents
  • Risk Factors
  • Proportional Hazards Models
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Platelet Aggregation Inhibitors
  • Myocardial Infarction
  • Multivariate Analysis
  • Middle Aged
  • Male
  • Immunoglobulin Fab Fragments